ZIFNELA

Trademark usage description

pharmaceutical preparations and substances for use in oncology and for the treatment of cardiovascular diseases and disorders, respiratory diseases an Read More

Classification Information

Class [005]
Pharmaceutical preparations and substances for use in oncology and for the treatment of cardiovascular diseases and disorders, respiratory diseases and disorders, pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely, diabetes, hypoglycaemia, gout, osteoarthritis, anemia, obesity and hypothyroidism; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely central nervous system infections, brain diseases, depression, anxiety, central nervous system movement disorders, and spinal cord diseases; pharmaceutical preparations and substances for the treatment of diseases and disorders of the peripheral nervous system, namely cranial and spinal neuropathies, autonomic neuropathies, sensorimotor neuropathies and plexopathies; pharmaceutical preparations and substances for use in pain control and local and general anesthetics; pharmaceutical preparations, namely, anti-inflammatories; pharmaceutical preparations, namely, anti-infective

Classification kind code

Mark Details

Serial Number

1847499

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 55 on 20^th Aug 2019	Registered
Submitted for opposition 50 on 28^th Dec 2018	Allowed
Submitted for opposition 51 on 28^th Dec 2018	Allowance Notice Sent
Submitted for opposition 42 on 12^th Sept 2018	Advertised
Submitted for opposition 26 on 23^rd Aug 2018	Approved
Submitted for opposition 22 on 6^th Jul 2018	Search Recorded
Submitted for opposition 27 on 6^th Jul 2018	Approval Notice Sent
Submitted for opposition 31 on 19^th Jul 2017	Formalized
Submitted for opposition 1 on 17^th Jul 2017	Created
Submitted for opposition 30 on 14^th Jul 2017	Filed